Clinical Trial Update: A Study to Evaluate Multiple Doses of GLPG2222 in Adult Subjects With Cystic Fibrosis [Phase 2]

View source ↗

Summary

Phase 2 trial update for GLPG2222 in adults with cystic fibrosis has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Drugs mentioned

• GLPG2222

Snippet

Sponsor: Galapagos NV | Conditions: Cystic Fibrosis | Phase 2 | Status: COMPLETED | Results posted: 2018-11-16